Literature DB >> 19270058

Effective induction of cell death on adult T-cell leukaemia cells by HLA-DRbeta-specific small antibody fragment isolated from human antibody phage library.

Satoshi Muraoka1, Yuji Ito, Masaki Kamimura, Masanori Baba, Naomichi Arima, Yasuo Suda, Shuhei Hashiguchi, Masaharu Torikai, Toshihiro Nakashima, Kazuhisa Sugimura.   

Abstract

By a biopanning method using cell sorter, we quickly isolated an antibody phage clone (S1T-A3) specific to human T-lymphotropic virus type 1-carrying T-cell line S1T from a human single chain Fv (scFv) antibody phage library. This scFv antibody bound to HTLV-1-carrying T-cell lines including MT-2, MT-4 and M8166 other than S1T, but not to non-HTLV-1-carrying T-cell lymphomas such as Jurkat and MOLT4 cells. Interestingly, this antibody induced the cell death on S1T cells very quickly (< 30 min). We tried to identify the target molecules by western blotting and mass spectrometric analysis, revealing that the target antigen was HLA class II DR. The cell death was induced only in dimmer form of scFv (diabody) and at 15-fold lower concentration than that of a fusion protein of scFv and human IgG Fc [(scFv)(2)-Fc] or anti HLA-DR mouse whole antibody L243. Thus, S1T-A3 diabody is a small antibody fragment with agonistic activity to induce cell death through HLA-DR. This is the first report elucidating that diabody specific to HLA-DR is effective to induce the cell death in T-cell malignancy especially adult T-cell leukaemic cell line.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270058     DOI: 10.1093/jb/mvp039

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Regulation of T cell response by blocking the ICOS signal with the B7RP-1-specific small antibody fragment isolated from human antibody phage library.

Authors:  Masatoshi Maeda; Yuji Ito; Takaaki Hatanaka; Shuhei Hashiguchi; Masaharu Torikai; Toshihiro Nakashima; Kazuhisa Sugimura
Journal:  MAbs       Date:  2009-09-26       Impact factor: 5.857

2.  Targeting acute myeloid cell surface using a recombinant antibody isolated from whole-cell biopanning of a phage display human scFv antibody library.

Authors:  Thitima Sumphanapai; Kerry Chester; Surasak Sawatnatee; Jenny Yeung; Montarop Yamabhai
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

3.  Novel cancer-specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long-term survival.

Authors:  Sayaka Takagi-Maeda; Satoshi Yajima; Takashi Suzuki; Katsuaki Usami; Nobuaki Takahashi; Rinpei Niwa; Hideaki Shimada
Journal:  Cancer Sci       Date:  2022-04-18       Impact factor: 6.518

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.